Article Text

Position paper on the use of botulinum toxin in cerebral palsy
  1. Medical Information Manager
  2. Allergan Limited
  3. Coronation Road
  4. High Wycombe, Bucks HP12 3SH, UK

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Editor,—Contrary to the statement by Carret al that botulinum toxin is currently unlicensed for use in the treatment of patients with cerebral palsy,1 we would like to inform your readers that the Botox brand of botulinum toxin (Allergan, High Wycombe, Bucks, UK) is currently licensed for the treatment of cerebral palsy as follows: In hospital specialist centres with appropriately trained personnel, of dynamic equinus foot deformity due to spasticity in ambulant paediatric cerebral palsy patients, two years of age or older.

    Botox is currently the only brand licensed for this indication.